Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Cat Vaccines Market

Cat Vaccines Market Size

  • Report ID: GMI12323
  • Published Date: Nov 2024
  • Report Format: PDF

Cat Vaccines Market Size

The global cat vaccines market size was valued at USD 1.1 billion in 2024 and is estimated to grow at a CAGR of 9.2% from 2025 to 2034. The growth of the market is fueled by several key factors, including the increasing awareness of animal healthcare and the rising number of pet owners worldwide.

 

Vaccination is crucial for protecting cats against various diseases like feline leukemia, feline panleukopenia, feline respiratory diseases, and rabies, which are prevalent in both domestic and stray cat populations. As more pet owners recognize the importance of preventive healthcare for their cats, the demand for vaccines has surged.
 

Additionally, the increasing focus on zoonotic diseases, which can be transmitted between animals and humans, has led to heightened awareness about the necessity of vaccinations in preventing such diseases, especially rabies. Thus, these factors are collectively contributing to the increased adoption of companion animal vaccines including cat vaccines, thereby driving the market growth. Moreover, the increased adoption of pet insurance and pet care products and services further supports the market expansion.
 

Cat vaccines are a subset of animal vaccines designed to protect companion animals, particularly cats, from various infectious diseases. These vaccines include vaccines, such as those for feline leukemia and feline respiratory diseases, as well as vaccines for less common conditions like rabies. By stimulating the immune system, cat vaccines help prevent the spread of these diseases, ensuring the health and well-being of domestic and outdoor cats.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global cat vaccines industry was valued at USD 1.1 billion in 2024 and is estimated to grow at a 9.2% CAGR from 2025 to 2034, driven by increasing awareness of animal healthcare and rising pet ownership worldwide.

The modified/attenuated live segment accounted for a 50.5% market share in 2024 due to its high efficacy, robust immune response, and cost-effectiveness, making it a top choice for veterinarians and pet owners.

The U.S. cat vaccines market was valued at USD 378.7 million in 2024, supported by a large pet-owning population and a strong veterinary infrastructure.

Key players in the industry include Bioveta, Boehringer Ingelheim, Durvet, Elanco, Indian Immunologicals, INTAS Animal Health, Merck, Spectra, Virbac, and Zoetis.

Cat Vaccines Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 10
  • Tables & Figures: 107
  • Countries covered: 19
  • Pages: 130
 Download Free Sample